260 related articles for article (PubMed ID: 18514220)
1. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Yu X; McGraw PA; House FS; Crowe JE
J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
[TBL] [Abstract][Full Text] [Related]
2. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults.
Kitamura K; Yamada K; Kuzushima K; Morishima T; Morishima Y; Yamamoto N; Nishiyama Y; Ohya K; Yamaguchi H
J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739
[TBL] [Abstract][Full Text] [Related]
4. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
5. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
6. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
Panova I; Gustafsson B
Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
[TBL] [Abstract][Full Text] [Related]
7. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
8. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
[TBL] [Abstract][Full Text] [Related]
9. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
Chiorazzi N; Wasserman RL; Kunkel HG
J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
[TBL] [Abstract][Full Text] [Related]
10. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
11. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
Kato M; Sasamori E; Chiba T; Hanyu Y
J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
[TBL] [Abstract][Full Text] [Related]
12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
13. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique.
Alvarado G; Crowe JE
Methods Mol Biol; 2016; 1442():63-76. PubMed ID: 27464688
[TBL] [Abstract][Full Text] [Related]
14. The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion.
Pratt M; Mikhalev A; Glassy MC
Hybridoma; 1987 Oct; 6(5):469-77. PubMed ID: 3500113
[TBL] [Abstract][Full Text] [Related]
15. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
16. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report.
Hulette CM; Effros RB; Dillard LC; Walford RL
Am J Pathol; 1985 Oct; 121(1):10-4. PubMed ID: 2996358
[TBL] [Abstract][Full Text] [Related]
17. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
18. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
19. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
